Praful Ramineni, MD
Plastic Surgery · Washington, DCNPI 1003977604
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.7%), gifts and speaking fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 72.8% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $3,421 and has fallen 88.6% since, to $391 in 2025.
Across 47 payments — averaging $118.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Mentor Worldwide LLC$299
- Galderma Laboratories, L.p.$252
- Baxter Healthcare$245
- Smith+Nephew$142
- TELA Bio, Inc.$131
- plus $449 from 9 others
What the payments were for
- Speaking & faculty fees$1503%
- Food & beverage$2,72049%
- Education$200%
- Gifts$2,70048%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 17 | $4,072 |
| Mentor Worldwide LLC | 5 | $299 |
| Galderma Laboratories, L.p. | 8 | $252 |
| Baxter Healthcare | 3 | $245 |
| Smith+Nephew | 2 | $142 |
| TELA Bio, Inc. | 2 | $131 |
| Acelrx Pharmaceuticals, Inc. | 1 | $125 |
| Davol Inc. | 2 | $122 |
| KCI USA, Inc. | 1 | $58 |
| TEI Biosciences Inc | 1 | $38 |
| Mimedx Group, Inc. | 1 | $24 |
| Motiva USA, LLC | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $23 |
| Organogenesis Inc. | 1 | $20 |
| Bard Peripheral Vascular, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,590 in reported general payments places this provider in the 60th percentile of 34 plastic surgery providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic surgery in Washington
- Paul RuffWashington$399K
- Kelly BoldenWashington$160K
- Rajiv ParikhWashington$54K
- Kenneth FanWashington$53K
- Wendy ChenWashington$43K
- Bharat RanganathWashington$26K
- Vikisha FrippWashington$21K
- Jessica WangWashington$7K
- Catherine HannanWashington$7K
- Ximena PinellWashington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.